Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q1 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.